










|
|
THOUGHT-LEADERS PERSPECTIVES, 1995
|
Immunotherapy for AML
Michael A. Caligiuri, MD
Associate Professor of Medicine
Roswell Park Cancer Center
|
|
Allogeneic BMT for AML
Frederick R. Applebaum, MD
Director, Clinical Research Division
Member, Fred Hutchinson Cancer Research Center
Professor of Medicine
University of Washington
|
|
Autologous BMT for AML
Malcolm Brenner, MD, PhD
Director of Division of Bone Marrow Transplant
and Gene Therapy Program
St. Jude Children's Research Hospital
Professor, Department of Pediatrics and Medicine
University of Tennessee
|
Top - Leukemia Library Index
©Copyright 1995-2012 Ultitech, Inc. All Rights Reserved.
|